Lacidipine has antiatherosclerotic effects independent of its actions on lipid metabolism and blood pressure

Vascular Pharmacology

Volumn 53, Issue 5-6, 2010, Pages 193-199

  Yetik Anacak, Günay ^a   Üstünes, Levent ^a   Dilsiz, Ozlem Yilmaz ^a   Ergul, Adviye ^b  

^a EGE UNIVERSITY   (Turkey)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

5 HT sensitivity; Collar induced atherosclerosis; Intimal thickening; Lacidipine; MMP 9; Nitric oxide; Rabbit carotid artery; Vascular reactivity

Indexed keywords

3 NITROTYROSINE; ACETYLCHOLINE; CHOLESTEROL; GELATINASE B; LACIDIPINE; NITRIC OXIDE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DRUG EFFECT; DRUG SENSITIVITY; ENDOTHELIUM; FEMALE; HEART PROTECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIPID METABOLISM; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAINING; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VASCULAR DISEASE; VASODILATATION;

ANIMALS; ATHEROSCLEROSIS; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CAROTID ARTERIES; DIHYDROPYRIDINES; ENDOTHELIUM, VASCULAR; FEMALE; ISOMETRIC CONTRACTION; LIPID METABOLISM; MALE; MATRIX METALLOPROTEINASE 9; NITRIC OXIDE; OXIDATIVE STRESS; RABBITS; TUNICA INTIMA;

EID: 78349308923     PISSN: 15371891     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vph.2010.08.003     Document Type: Article

References (45)

1. Awad A.E., Kandalam V., Chakrabarti S., Wang X., Penninger J.M., Davidge S.T., Oudit G.Y. & Kassiri Z., 2010. Tumor necrosis factor induces matrix metalloproteinases in cardiomyocytes and cardiofibroblasts differentially via superoxide production in a PI3Kgamma-dependent manner. Am J Physiol Cell Physiol, 298, C679-92.
2. Back M., Ketelhuth D.F. & Agewall S., 2010. Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis, 52, 410-28.
3. Beesley J.H.A., Martin J. Ultrastructural assessment of lesion development in the collared rabbit carotid artery model. Cell Mater. 1992, 2:201-203.
4. Bellosta S., Canavesi M., Favari E., Cominacini L., Gaviraghi G., Fumagalli R., Paoletti R., Bernini F. Lacidipine [correction of Lalsoacidipine] modulates the secretion of matrix metalloproteinase-9 by human macrophages. J. Pharmacol. Exp. Ther. 2001, 296:736-743.
5. Bernini F., Bellosta S., Didoni G., Fumagalli R. Calcium antagonists and cholesteryl ester metabolism in macrophages. J. Cardiovasc. Pharmacol. 1991, 18(Suppl 10):S42-S45.
6. Bernini F., Corsini A., Raiteri M., Soma M.R., Paoletti R. Effects of lacidipine on experimental models of atherosclerosis. J. Hypertens. Suppl. 1993, 11:S61-S66.
7. Bernini F., Canavesi M., Bernardini E., Scurati N., Bellosta S., Fumagalli R. Effect of lacidipine on cholesterol esterification: in vivo and in vitro studies. Br. J. Pharmacol. 1997, 122:1209-1215.
8. Bond G., Dal Palu C., Hansson L., Magnani B., Mancia G., Neiss A., Rahn K.H., Reid J.L., Rodicio J.L., Safar M., et al. The E.L.S.A. trial: protocol of a randomized trial to explore the differential effect of antihypertensive drugs on atherosclerosis in hypertension. J. Cardiovasc. Pharmacol. 1994, 23(Suppl 5):S85-S87.
9. Booth R.F., Martin J.F., Honey A.C., Hassall D.G., Beesley J.E., Moncada S. Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989, 76:257-268.
10. Brown D.L., Hibbs M.S., Kearney M., Loushin C., Isner J.M. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 1995, 91:2125-2131.
11. Chan E.C., Datla S.R., Dilley R., Hickey H., Drummond G.R., Dusting G.J. Adventitial application of the NADPH oxidase inhibitor apocynin in vivo reduces neointima formation and endothelial dysfunction in rabbits. Cardiovasc. Res. 2007, 75:710-718.
12. Cristofori P., Lanzoni A., Quartaroli M., Pastorino A.M., Zancanaro C., Cominacini L., Gaviraghi G., Turton J. The calcium-channel blocker lacidipine reduces the development of atherosclerotic lesions in the apoE-deficient mouse. J. Hypertens. 2000, 18:1429-1436.
13. Cristofori P., Crivellente F., Campagnola M., Pasini A.F., Garbin U., Rigoni A., Tosetti M., Turton J., Faustinelli I., Cominacini L. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice treated with lacidipine is associated with a decreased susceptibility of low-density lipoprotein to oxidation. Int. J. Exp. Pathol. 2004, 85:105-114.
14. Cristofori P.G., Crivellente F.A., Faustinelli I., Lanzoni A.R., Lazzarini C., Vecchiato E., Andreoli M., Turton J.A., Zancanaro C., Crespi F.M. Involvement of the nitric oxide system in the anti-atherosclerotic potential of lacidipine in the ApoE-deficient mouse: a morphological, functional, and electrochemical study. Toxicol. Pathol. 2004, 32:493-499.
15. Cromheeke K.M., Kockx M.M., De Meyer G.R., Bosmans J.M., Bult H., Beelaerts W.J., Vrints C.J., Herman A.G. Inducible nitric oxide synthase colocalizes with signs of lipid oxidation/peroxidation in human atherosclerotic plaques. Cardiovasc. Res. 1999, 43:744-754.
16. Datta R., Yoshinaga K., Kaneki M., Pandey P., Kufe D. Phorbol ester-induced generation of reactive oxygen species is protein kinase cbeta-dependent and required for SAPK activation. J. Biol. Chem. 2000, 275:41000-41003.
17. De Meyer G.R., Bult H., Herman A.G. Selective muscarinic alterations of nitric oxide-mediated relaxations by neointima. J. Cardiovasc. Pharmacol. 1992, 20(Suppl 12):S205-S207.
18. De Meyer G.R., Bult H., Ustunes L., Kockx M., Jordaens F.H., Zonnekeyn L.L., Herman A.G. Vasoconstrictor responses after neo-intima formation and endothelial removal in the rabbit carotid artery. Br. J. Pharmacol. 1994, 112:471-476.
19. Fanburg Bl L.S. A new role for an old molecule: serotonin as a mitogen. Am. J. Physiol. 1997, 16:L795-L806.
20. Fukada S.Y., Correa F.M., Ramalho L.N., Mizusaki C.I., De Oliveira A.M. Perivascular injury leads to a reduction in vascular reactivity of the collared and to an enhancement on contralateral carotid artery of rats. Cardiovasc. Pathol. 2004, 13:251-259.
21. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 1994, 94:2493-2503.
22. Geerts I.S., Matthys K.E., Herman A.G., Bult H. Involvement of 5-HT1B receptors in collar-induced hypersensitivity to 5-hydroxytryptamine of the rabbit carotid artery. Br. J. Pharmacol. 1999, 127:1327-1336.
23. Geerts I.S., De Meyer G.R., Bult H. Collar-induced elevation of mRNA and functional activity of 5-HT(1B) receptor in the rabbit carotid artery. Br. J. Pharmacol. 2000, 131:1723-1731.
24. Herbette L.G., Mason P.E., Gaviraghi G., Tulenko T.N., Mason R.P. The molecular basis for lacidipine's unique pharmacokinetics: optimal hydrophobicity results in membrane interactions that may facilitate the treatment of atherosclerosis. J. Cardiovasc. Pharmacol. 1994, 23(Suppl 5):S16-S25.
25. Hill P.B., Dora K.A., Hughes A.D., Garland C.J. The involvement of intracellular Ca(2+) in 5-HT(1B/1D) receptor-mediated contraction of the rabbit isolated renal artery. Br. J. Pharmacol. 2000, 130:835-842.
26. Kaumann A.J., Levy F.O. 5-hydroxytryptamine receptors in the human cardiovascular system. Pharmacol. Ther. 2006, 111:674-706.
27. Kerry Z., Yasa M., Akpinar R., Sevin G., Yetik G., Tosun M., Ozdemir N., Erhan Y., Ustunes L., Ozer A. Effects of nicardipine on collar-induced intimal thickening and vascular reactivity in the rabbit. J. Pharm. Pharmacol. 1999, 51:441-447.
28. Kerry Z., Yasa M., Sevin G., Reel B., Yetik Anacak G., Ozer A. Diverse effects of calcium channel blockers in the collar model. Acta Cardiol 2005, 60:493-499.
29. Kojda G., Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc. Res. 1999, 43:562-571.
30. Krenek P., Salomone S., Kyselovic J., Wibo M., Morel N., Godfraind T. Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats. Hypertension 2001, 37:1124-1128.
31. Nelson K.K., Melendez J.A. Mitochondrial redox control of matrix metalloproteinases. Free Radic. Biol. Med. 2004, 37:768-784.
32. Reel B., Oktay G., Ozkal S., Islekel H., Ozer E., Ozsarlak-Sozer G., Cavdar Z., Akhisaroglu S.T., Kerry Z. MMP-2 and MMP-9 alteration in response to collaring in rabbits: the effects of endothelin receptor antagonism. J. Cardiovasc. Pharmacol. Ther. 2009, 14:292-301.
33. Ross R. Atherosclerosis-an inflammatory disease. N Engl J. Med. 1999, 340:115-126.
34. Sharma S.K., Zahradka P., Chapman D., Kumamoto H., Takeda N., Dhalla N.S. Inhibition of serotonin-induced vascular smooth muscle cell proliferation by sarpogrelate. J. Pharmacol. Exp. Ther. 1999, 290:1475-1481.
35. Sobey C.G., Dusting G.J., Woodman O.L. Enhanced vasoconstriction by serotonin in rabbit carotid arteries with atheroma-like lesions in vivo. Clin. Exp. Pharmacol. Physiol. 1991, 18:367-370.
36. Soma M.R., Donetti E., Parolini C., Barberi L., Paoletti R., Fumagalli R., Catapano A.L. Effect of lacidipine on the carotid intimal hyperplasia induced by cuff injury. J. Cardiovasc. Pharmacol. 1994, 23(Suppl 5):S71-S74.
37. Soma M.R., Donetti E., Seregni R., Barberi L., Fumagalli R., Paoletti R., Catapano A.L. Effect of lacidipine on fatty and proliferative lesions induced in hypercholesterolaemic rabbits. Br. J. Pharmacol. 1996, 118:215-219.
38. Sozmen E.Y., Kerry Z., Uysal F., Yetik G., Yasa M., Ustunes L., Onat T. Antioxidant enzyme activities and total nitrite/nitrate levels in the collar model. Effect of nicardipine. Clin. Chem. Lab. Med. 2000, 38:21-25.
39. Spieker C., Zidek W. The impact of lacidipine, a novel dihydropyridine calcium antagonist, on carbohydrate and lipid metabolism. J. Cardiovasc. Pharmacol. 1995, 25(Suppl 3):S23-S26.
40. Ustunes L., Yasa M., Kerry Z., Ozdemir N., Berkan T., Erhan Y., Ozer A. Effect of verapamil on intimal thickening and vascular reactivity in the collared carotid artery of the rabbit. Br. J. Pharmacol. 1996, 118:1681-1688.
41. Van Put D.J., Van Hove C.E., De Meyer G.R., Wuyts F., Herman A.G., Bult H. Dexamethasone influences intimal thickening and vascular reactivity in the rabbit collared carotid artery. Eur. J. Pharmacol. 1995, 294:753-761.
42. Verbeuren T.J., Jordaens F.H., Zonnekeyn L.L., Van Hove C.E., Coene M.C., Herman A.G. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits. Circ. Res. 1986, 58:552-564.
43. Yasa M., Kerry Z., Yetik G., Sevin G., Reel B., Ozdemir N., Erhan Y., Ustunes L., Berkan T., Ozer A. Effects of treatment with FK409, a nitric oxide donor, on collar-induced intimal thickening and vascular reactivity. Eur. J. Pharmacol. 1999, 374:33-39.
44. Zanchetti A., Bond M.G., Hennig M., Neiss A., Mancia G., Dal Palu C., Hansson L., Magnani B., Rahn K.H., Reid J.L., Rodicio J., Safar M., Eckes L., Rizzini P. Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation 2002, 106:2422-2427.
45. Zanchetti A., Bond M.G., Hennig M., Tang R., Hollweck R., Mancia G., Eckes L., Micheli D. Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA). J. Hypertens. 2004, 22:1201-1212.